Association of antiseizure medications and adverse cardiovascular events: A global health federated network analysis

Joséphine Mayer; Gashirai K. Mbizvo; Tommaso Bucci; Anthony G Marson; Professor Gregory Lip

doi:10.1111/epi.17922

Back

Association of antiseizure medications and adverse cardiovascular events: A global health federated network analysis

Article 2024 en

Abstract

1 min read

Carbamazepine and valproate were associated with increased CE risks compared to lamotrigine. Cardiovascular risk factor monitoring and careful follow-up should be considered for these patients.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2024

Risk of death, thrombotic and hemorrhagic events in anticoagulated patients with atrial fibrillation and systemic autoimmune diseases: an analysis from a global federated dataset

Tommaso Bucci, Chiara Cardamone, Massimo Triggiani, Paul R. J. Ames, Professor Gregory Lip

Article2024

One-year risk of all-cause death and major cardiovascular events in patients presenting with hypertensive crisis. A report from a global federated research health network

Tommaso Bucci, Antonis Argyris, Afrah Alsomali, Stephan Lam, Luigi Gerra, Riccardo Proietti, Gareth Beevers, Eduard Shantsila, Alena Shantsila, Professor Gregory Lip

Article2023

Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study

Eng Soo Yap, Willem M. Lijfering, J.F. Timp, Frits R. Rosendaal, Suzanne C. Cannegieter, Luuk J.J. Scheres

eJHaem

Article2007

Antiepileptic Drugs and Mood Stability

Benedikt L. Amann, Heinz Grunze, Eduard Vieta, Michael Trimble

Article2009

Is Anticonvulsant Treatment of Mania a Class Effect? Data from Randomized Clinical Trials

Adriane Ribeiro Rosa, Konstantinos Ν. Fountoulakis, Melina Siamouli, Xénia Gonda, Eduard Vieta